Top Markets
Coin of the day
Captor Therapeutics Spolka Akcyjna Captor Therapeutics Spolka Akcyjna

Captor Therapeutics Spolka Akcyjna

CTX
Classificação em ações #20486
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the... Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. Its products in various stages of development include CT-03, which has completed the Phase 1 clinical trials for the treatment of non-small cell lung cancer, triple-negative breast cancer, as well as cancers of the blood, lymphatic system, and bone marrow; and CT-01, which also completed the Phase 1 clinical trials for the treatment of hepatocellular carcinoma, through degradation of oncofetal transcription factor. The company was incorporated in 2015 and is headquartered in Wroclaw, Poland.
Preço da ação
$20.38
Valor de mercado
$129.09M
Variação (1 dia)
-0.82%
Variação (1 ano)
80.91%
País
PL
Negociar Captor Therapeutics Spolka Akcyjna (CTX)

Categoria

Histórico de preços das ações de Captor Therapeutics Spolka Akcyjna (CTX)
Preço de fecho mais alto: $20.25 em 2026-08-01

Preço de fecho mais baixo: $45.81 em 2021-04-01
Histórico de preços das ações da Captor Therapeutics Spolka Akcyjna de 2021 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -1.92%
2025 68.95%
2024 -54.45%
2023 -32.61%
2022 -15.45%
2021 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$119.27 -15.19%
AU
$763.95 8.09%
CH